Pharmaceutical company perspectives on current safety risk communications in Japan

In 1987, a group infection of hepatitis in patients receiving a contaminated fibrinogen product was first reported to the Japanese regulatory agency. Eventually, this serious drug incident involved more than 10,000 cases of infection. In response, the Government of Japan established a responding ins...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Urushihara, Hisashi, Kobashi, Gen, Masuda, Hideaki, Taneichi, Setsuko, Yamamoto, Michiko, Nakayama, Takeo, Kawakami, Koji, Matsuda, Tsutomu, Ohta, Kaori, Sugimori, Hiroki
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer International Publishing 2014
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3921345/
https://ncbi.nlm.nih.gov/pubmed/24555168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-51
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg